Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene affects the expression of ZMIZ1 mRNA | affects expression | 20106945
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of ZMIZ1 mRNA | decreases expression | 20064835
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ZMIZ1 mRNA | decreases expression | 19150397 20382639
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of ZMIZ1 mRNA | increases expression | 15336504
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of ZMIZ1 mRNA | increases expression | 20106945
|
D009151 |
Mustard Gas |
Mustard Gas affects the expression of ZMIZ1 mRNA | affects expression | 15651846
|
D020849 |
Raloxifene |
Raloxifene affects the expression of ZMIZ1 mRNA | affects expression | 14699072
|
D020849 |
Raloxifene |
[Raloxifene co-treated with ESR2 protein] results in decreased expression of ZMIZ1 mRNA | affects cotreatment|decreases expression | 19059307
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of ZMIZ1 mRNA | affects expression | 14699072
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR2 protein] results in decreased expression of ZMIZ1 mRNA | affects cotreatment|decreases expression | 19059307
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ZMIZ1 mRNA | increases expression | 20106945
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.92 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.18 | 15322242 11752688 14514962 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.03 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.78 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.71 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.88 | 17308373 17451421 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.58 | 15800139 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.17 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.38 | 19183758 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
2.77 | 10378619 |
MESH:D001768 |
Blister |
|
Mustard Gas |
5.50 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.29 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.17 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.91 | 15746008 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.78 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.97 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
1.97 | 17242785 17595753 16837676 17440819 16912660 15758505 17952589 17261762 17893378 15775269 15572757 17049068 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.97 | 17242785 18815881 18351453 21152245 20065188 19410462 16818667 16202921 18997820 19059307 18855134 19221464 18425577 19189210 19155303 20005174 20135344 18984771 18821012 20390343 19289846 19244106 19142967 20544844 19066611 15565566 18629630 15668708 11161223 16873071 19011961 19084267 17893378 17049068 16273361 19288272 19487384 17440819 19200415 17261762 19103187 19189212 19115204 20859285 21138602 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.97 | 20435547 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
5.50 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
5.35 | 17687719 10378619 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.99 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.81 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
1.84 | 16924424 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.10 | 20419170 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
10.27 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
10.27 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.49 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.60 | 15775269 |
MESH:D002446 |
Celiac Disease |
marker/mechanism |
|
| 20190752 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.09 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.09 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.38 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.09 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.19 | 15668235 15340226 12621046 16354765 8697196 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.92 | 15800139 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 20055451 10048152 15322242 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.67 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.38 | 17474826 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
9.76 | 17451421 17308373 15920148 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
9.76 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.59 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.93 | 11462148 |
MESH:D004487 |
Edema |
|
Mustard Gas |
12.99 | 11402378 11428631 11428647 9260866 |
MESH:D004487 |
Edema |
|
Raloxifene |
12.99 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
12.99 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.28 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
10.20 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
10.20 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.19 | 19155303 20544844 16202921 17893378 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.25 | 9294722 10568697 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
5.50 | 9357497 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.52 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.52 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.19 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
14.62 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
14.62 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
14.62 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.37 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.76 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.87 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.52 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.52 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.52 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.56 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.97 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.82 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.82 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.69 | 11110106 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.76 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.58 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.20 | 15340226 16120746 12621046 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.42 | 8697196 18606429 16354765 15340226 16959395 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
9.04 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
9.04 | 17577099 15787275 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
9.04 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
8.99 | 11428647 8975870 9260866 17524151 11428631 9357497 11402378 11428620 16001271 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
8.99 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.99 | 12200463 12878042 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.58 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.82 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.46 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.98 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
7.98 | 18625569 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.76 | 16973256 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.32 | 17567588 15342952 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.34 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.34 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.82 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
7.82 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.82 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.24 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
3.60 | 18161513 18702808 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
5.03 | 20464547 17053015 6695378 20135361 18569708 20064080 18520028 20869020 18816296 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
5.03 | 3148597 8781369 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
5.03 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
5.03 | 11884234 19555203 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.10 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.76 | 11731420 19196723 14580682 19196722 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.92 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.91 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.52 | 15990972 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.16 | 16801185 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.93 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.37 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.60 | 16497877 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.21 | 12213967 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.93 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.63 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.58 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.27 | 11141357 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.38 | 19189210 19196722 19200415 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.82 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.50 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.49 | 14600291 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
4.23 | 16761898 7688884 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.53 | 15775268 19059307 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.49 | 15758505 17823083 17893378 15579764 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.62 | 12520081 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
4.06 | 15727166 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.84 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.44 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.53 | 11118676 11222880 11896295 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.53 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.53 | 16536755 15731164 16220300 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.53 | 15067354 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
4.43 | 18058305 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.30 | 16882103 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
3.00 | 17720292 17894541 17620002 17266442 10334151 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.93 | 15770314 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.12 | 18990726 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
2.76 | 15451306 12880345 16961503 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
9.98 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
9.98 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.98 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.67 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.38 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20155912 2093021 |
MESH:D020521 |
Stroke |
|
Raloxifene |
4.01 | 16837676 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.28 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
5.58 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.82 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
8.82 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
8.82 | 16712894 8653321 17572228 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.36 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.97 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.58 | 16837676 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.93 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.62 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.82 | 17120751 |